Addressing the Challenges of Phenotyping Pediatric Pulmonary Vascular Disease
Kara N. Goss, Allen D. Everett, Peter M. Mourani, Christopher D. Baker, Steven H. Abman
March 2017
DOI: 10.1086/689750
Novel Methods in Pulmonary Hypertension Phenotyping in the Age of Precision Medicine (2015 Grover Conference Series)
Jarrod W. Barnes, Adriano R. Tonelli, Gustavo A. Heresi, Jennie E. Newman, Noël E. Mellor, David E. Grove, Raed A. Dweik
December 2016
DOI: 10.1086/688847
Pulmonary Vascular and Ventricular Dysfunction in the Susceptible Patient (2015 Grover Conference Series)
Bradley A. Maron, Roberto F. Machado, Larissa Shimoda
December 2016
DOI: 10.1086/688315
Integration of Complex Data Sources to Provide Biologic Insight into Pulmonary Vascular Disease (2015 Grover Conference Series)
Evan L. Brittain, Stephen Y. Chan
September 2016
DOI: 10.1086/686995
The Emerging Role of Epigenetics in Pulmonary Arterial Hypertension: An Important Avenue for Clinical Trials (2015 Grover Conference Series)
Jessica H. Huston, John J. Ryan
September 2016
DOI: 10.1086/687765
Novel Signaling Pathways in Pulmonary Arterial Hypertension (2015 Grover Conference Series)
Keytam S. Awad, James D. West, Vinicio de Jesus Perez, Margaret MacLean
September 2016
DOI: 10.1086/688034
In the above articles, the following funding statement should have been included:
The American Thoracic Society and the conference organizing committee gratefully acknowledge the educational grants provided for the support of this conference by Actelion Pharmaceuticals US, Inc., Gilead Sciences, Inc., Lung Biotechnology, and United Therapeutics Corporation. Additionally, the American Thoracic Society is grateful for the support of the Grover Conference by the American Heart Association, the Cardiovascular Medical Research and Education Fund, and the National Institute of Health.